ITMI20002855A1 - COSMETIC USE OF CARNOSINE - Google Patents
COSMETIC USE OF CARNOSINE Download PDFInfo
- Publication number
- ITMI20002855A1 ITMI20002855A1 IT2000MI002855A ITMI20002855A ITMI20002855A1 IT MI20002855 A1 ITMI20002855 A1 IT MI20002855A1 IT 2000MI002855 A IT2000MI002855 A IT 2000MI002855A IT MI20002855 A ITMI20002855 A IT MI20002855A IT MI20002855 A1 ITMI20002855 A1 IT MI20002855A1
- Authority
- IT
- Italy
- Prior art keywords
- carnosine
- proteins
- action
- cosmetic
- produced during
- Prior art date
Links
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 title claims description 35
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 title claims description 35
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 title claims description 34
- 108010087806 Carnosine Proteins 0.000 title claims description 34
- 229940044199 carnosine Drugs 0.000 title claims description 34
- 239000002537 cosmetic Substances 0.000 title claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 230000009471 action Effects 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 239000000499 gel Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 7
- 230000036252 glycation Effects 0.000 claims description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- 239000003053 toxin Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000032683 aging Effects 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 8
- 150000001728 carbonyl compounds Chemical class 0.000 description 7
- 239000002304 perfume Substances 0.000 description 7
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 5
- 229960001631 carbomer Drugs 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- DJNTZVRUYMHBTD-UHFFFAOYSA-N Octyl octanoate Chemical compound CCCCCCCCOC(=O)CCCCCCC DJNTZVRUYMHBTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000003284 homeostatic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229940094944 saccharide isomerate Drugs 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- REDJROVXYGNERA-UHFFFAOYSA-N C(C=C)(=O)O.C(CCCCCCC(C)C)(=O)O Chemical compound C(C=C)(=O)O.C(CCCCCCC(C)C)(=O)O REDJROVXYGNERA-UHFFFAOYSA-N 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- -1 defoamers Substances 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-N disodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound [Na+].[Na+].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O ZGTMUACCHSMWAC-UHFFFAOYSA-N 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000005184 irreversible process Methods 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940061515 laureth-4 Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940044591 methyl glucose dioleate Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000006069 physical mixture Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000006950 reactive oxygen species formation Effects 0.000 description 1
- 229940080340 sodium dihydroxycetyl phosphate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- VDHLWCWZVFZQLZ-UHFFFAOYSA-M sodium;bis(2-hydroxyhexadecyl) phosphate Chemical compound [Na+].CCCCCCCCCCCCCCC(O)COP([O-])(=O)OCC(O)CCCCCCCCCCCCCC VDHLWCWZVFZQLZ-UHFFFAOYSA-M 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
Descrizione del brevetto per invenzione industriale avente per Description of the patent for an industrial invention having for
titolo: title:
“USO COSMETICO DELLA CARNOSINA" "COSMETIC USE OF CARNOSINE"
La presente invenzione ha per oggetto Fuso della carnosina in cosmetica, in particolare per prevenire e combattere gli inestetismi dovuti all’azione sulle proteine di metaboliti tossici con funzione carbonilica prodotti durante la reazione di glicazione. The present invention relates to the use of carnosine in cosmetics, in particular to prevent and combat imperfections due to the action on proteins of toxic metabolites with carbonyl function produced during the glycation reaction.
Sfondo dell’invenzione Background of the invention
L’invecchiamento cutaneo è un processo irreversibile geneticamente programmato ed accelerato da elementi esterni, quali luce solare, radiazioni, inquinamento. L’azione combinata di fattori endogeni ed esogeni causa la formazione di speci reattive dell’ossigeno, come radicali e perossidi, considerate maggiori responsabili del processo degenerativo che porta all’invecchiamento delle cellule e dei componenti extracellulari del tessuto cutaneo. Skin aging is an irreversible process that is genetically programmed and accelerated by external elements, such as sunlight, radiation, pollution. The combined action of endogenous and exogenous factors causes the formation of reactive oxygen species, such as radicals and peroxides, which are considered to be more responsible for the degenerative process that leads to the aging of cells and extracellular components of the skin tissue.
L’ossidazione di substrati biologici quali zuccheri e lipidi di membrana innesca una cascata di reazioni, note complessivamente con il nome di glicazione, che convergono nella formazione di composti carbonilici (aldeidi e chetoni), altamente tossici, a cui è stato attribuito un ruolo chiave nella propagazione ed amplificazione del processo di invecchiamento. Tali addotti mostrano infatti particolare affinità e reattività nei confronti di macromolecole ad emivita lunga quali proteine strutturali (collagene, elastina) ed acidi nucleici. I substrati biologici interessati dall’azione deleteria dei composti carbonilici vanno incontro ad alterazioni con conseguente perdita di funzionalità. A livello cutaneo tale fenomeno si manifesta con la comparsa di modificazioni cellulari caratteristiche dell’ invecchiamento [R. Holliday, G. A. McFarland. Biochemistry. 65 (7), 991-97, 2000]. The oxidation of biological substrates such as sugars and membrane lipids triggers a cascade of reactions, known collectively as glycation, which converge in the formation of highly toxic carbonyl compounds (aldehydes and ketones), which have been attributed a key role in the propagation and amplification of the aging process. In fact, these adducts show particular affinity and reactivity towards long half-life macromolecules such as structural proteins (collagen, elastin) and nucleic acids. The biological substrates affected by the deleterious action of carbonyl compounds undergo alterations with consequent loss of functionality. At the skin level, this phenomenon manifests itself with the appearance of cellular changes characteristic of aging [R. Holliday, G. A. McFarland. Biochemistry. 65 (7), 991-97, 2000].
Le proteine della matrice extracellulare subiscono alterazioni delle catene laterali che portano a disorganizzazione, aggregazione, frammentazione, cross-linking. Il cedimento della microstruttura delle fibre del connettivo compromette le proprietà meccaniche della cute; ciò si traduce, a livello macroscopico, in rilassamento del tessuto e formazione di rughe, antiestetici segnali di una pelle senescente. The proteins of the extracellular matrix undergo alterations of the side chains that lead to disorganization, aggregation, fragmentation, cross-linking. The failure of the microstructure of the connective fibers compromises the mechanical properties of the skin; this translates, on a macroscopic level, into relaxation of the tissue and the formation of wrinkles, unsightly signs of aging skin.
La scienza cosmetica considera l’invecchiamento cutaneo una delle aree di maggiore interesse. Ne risulta una lunga lista di molecole di origine eterogenea studiate a tale scopo e proposte come in grado di ostacolare il chimismo delle specie reattive dell’ossigeno e di processi biochimici correlati. Cosmetic science considers skin aging one of the areas of greatest interest. The result is a long list of molecules of heterogeneous origin studied for this purpose and proposed as being able to hinder the chemism of reactive oxygen species and related biochemical processes.
La carnosina (β-alanil-L-istidina) è una sostanza fisiologica che è stata isolata per la prima volta circa cento anni fa. Si trova in concentrazioni fino a 20 mM nei tessuti innervati (muscoli ed encefalo) dei vertebrati. La maggior parte della letteratura sulla carnosina ne indica un ruolo quale anti-ossidante. Studi più recenti ne suggeriscono, invece, un’ulteriore funzionalità omeostatica. [A. Hipkiss, Int. J. Bioch. Celi Biol. Carnosine (β-alanyl-L-histidine) is a physiological substance that was first isolated about a hundred years ago. It is found in concentrations up to 20 mM in the innervated tissues (muscles and brain) of vertebrates. Most of the literature on carnosine points to its role as an antioxidant. More recent studies, on the other hand, suggest an additional homeostatic functionality. [TO. Hipkiss, Int. J. Bioch. Cell Biol.
1998, 30:863-868]. 1998, 30: 863-868].
Nonostante il ruolo fisiologico della molecola non sia stato ancora del tutto chiarito, le sono state attribuite numerose proprietà in vari campi di applicazione, incluso quello medico, nutrizionale e cosmetico, che contribuirebbero a considerarla una molecola con funzioni omeostatiche e protettive nei confronti del processo di invecchiamento. In particolare, l’uso della carnosina in campo cosmetico è stato proposto in applicazione come antiossidante (JP 4187610), come agente antiradicalico (EP 571390), nel trattamento di cute irritata per effetto dei raggi solari (W094/21245), per la cura di pelle screpolata (JP 4235111), come agente sbiancante cutaneo (JP 2221213). Although the physiological role of the molecule has not yet been fully clarified, it has been attributed numerous properties in various fields of application, including medical, nutritional and cosmetic, which would help to consider it a molecule with homeostatic and protective functions against the process of aging. In particular, the use of carnosine in the cosmetic field has been proposed in application as an antioxidant (JP 4187610), as an anti-radical agent (EP 571390), in the treatment of skin irritated by the effect of sunlight (W094 / 21245), for the treatment of cracked skin (JP 4235111), as a skin whitening agent (JP 2221213).
Descrizione dettagliata dell’invenzione Detailed description of the invention
Si è ora trovato che la carnosina può essere vantaggiosamente utilizzata in cosmetica per trattare o prevenire gli inestetismi dovuti all’azione sulle proteine di metaboliti tossici con funzione carbonilica prodotti durante la reazione di glicazione. It has now been found that carnosine can be advantageously used in cosmetics to treat or prevent imperfections due to the action on the proteins of toxic metabolites with carbonyl function produced during the glycation reaction.
La carnosina si è dimostrata infatti in grado di reagire con i composti carbonilici, derivanti dall’ossidazione di zuccheri e lipidi di membrana, responsabili dell’alterazione irreversibile di proteine. L’azione del dipeptide su tali addotti tossici blocca il loro effetto deleterio sui substrati bersaglio fisiologicamente determinati, quali le macromolecole proteiche del tessuto connettivo, intervenendo su una delle cause dell’invecchiamento del tessuto cutaneo e sulla formazione di rughe. Carnosine has in fact been shown to be able to react with carbonyl compounds, resulting from the oxidation of sugars and membrane lipids, responsible for the irreversible alteration of proteins. The action of the dipeptide on these toxic adducts blocks their deleterious effect on physiologically determined target substrates, such as the protein macromolecules of the connective tissue, intervening on one of the causes of aging of the skin tissue and on the formation of wrinkles.
L’invenzione fornisce pertanto metodi di trattamento cosmetico per ridurre o prevenire il danno tessutale provocato dall’azione di reattivi tossici, prodotti nel processo di invecchiamento, sulle proteine della matrice. The invention therefore provides cosmetic treatment methods to reduce or prevent tissue damage caused by the action of toxic reactants, produced in the aging process, on the proteins of the matrix.
L’efficacia d’azione della carnosina può essere dimostrata dai risultati degli esperimenti condotti in vitro sui composti carbonilici maggiormente tossici per le proteine, nel caso specifico il metilgliossale, derivato dicarbonilico endogeno, e il trans-2-exanale, un’aldeide α,βinsatura. The efficacy of carnosine action can be demonstrated by the results of the experiments conducted in vitro on the carbonyl compounds most toxic to proteins, in this specific case the methylglyoxal, an endogenous dicarbonyl derivative, and the trans-2-exanal, an α aldehyde, β unsaturated.
La reazione tra carnosina e un composto carbonilico è evidenziata sperimentalmente dal cambiamento dello spettro UV della miscela di reazione: classicamente si rileva un aumento di assorbanza intorno ai 280 nm. The reaction between carnosine and a carbonyl compound is experimentally highlighted by the change in the UV spectrum of the reaction mixture: classically, an increase in absorbance around 280 nm is detected.
Tale risultato è stato ottenuto incubando la carnosina con il metilgliossale. Metilgliossale 5 mM è stato aggiunto a carnosina equimolare in 100 mM di tampone fosfato a pH 7 per due ore. L’assorbanza della miscela di reazione, al termine del tempo di incubazione, aumenta di circa quattro volte rispetto al valore iniziale. This result was obtained by incubating carnosine with methylglyoxal. 5 mM methylglyoxal was added to equimolar carnosine in 100 mM phosphate buffer at pH 7 for two hours. The absorbance of the reaction mixture, at the end of the incubation time, increases about four times compared to the initial value.
Ulteriore conferma della capacità della carnosina di formare addotti con i composti carbonilici è stata ottenuta analizzando tramite gascromatografia la concentrazione di trans-2-exanale nello spazio di testa del vial contenente il dipeptide. Carnosina 5 mM è stata aggiunta all’aldeide in uguale concentrazione in tampone fosfato 5 mM a pH 7 e 0.12 M di KCl. 1 ml della soluzione ottenuta è stato sigillato in un vial ed incubato a 40°C per cinque ore. A tempi prestabiliti campioni di soluzione sono stati prelevati ed iniettati in colonna per l’analisi gas-cromatografica. La concentrazione di aldeide libera nello spazio di testa decresce linearmente nel corso dell’esperimento. Già dopo un’ora di incubazione la carnosina è in grado di abbattere la concentrazione di trans- 2-exanale del 44%. Further confirmation of the ability of carnosine to form adducts with carbonyl compounds was obtained by analyzing by gas chromatography the concentration of trans-2-exanal in the headspace of the vial containing the dipeptide. 5 mM carnosine was added to the aldehyde in equal concentration in 5 mM phosphate buffer at pH 7 and 0.12 M of KCl. 1 ml of the obtained solution was sealed in a vial and incubated at 40 ° C for five hours. At predetermined times, solution samples were taken and injected into the column for gas-chromatographic analysis. The concentration of free aldehyde in the headspace decreases linearly over the course of the experiment. Already after one hour of incubation, carnosine is able to reduce the concentration of trans-2-exanal by 44%.
La carnosina ha quindi dimostrato di essere particolarmente attiva nel contrastare l’azione dei composti carbonilici responsabili degli effetti visibili dell’invecchiamento, grazie alla sua capacità di “spegnerne” la reattività. Carnosine has therefore proved to be particularly active in counteracting the action of carbonyl compounds responsible for the visible effects of aging, thanks to its ability to "switch off" their reactivity.
L’invenzione riguarda inoltre formulazioni cosmetiche contenenti carnosina in concentrazione compresa tra lo 0.01% e il 10% in peso. The invention also relates to cosmetic formulations containing carnosine in a concentration between 0.01% and 10% by weight.
La carnosina può essere usata come principio attivo in soluzioni, emulsioni del tipo olio in acqua (O/A) o acqua in olio (A/O), in gel a diversi gradi di viscosità e diversa consistenza oppure come soluzione o lozione. Carnosine can be used as an active ingredient in solutions, oil-in-water (O / A) or water-in-oil (A / O) emulsions, in gels with different viscosity grades and different consistencies, or as a solution or lotion.
Le composizioni cosmetiche possono includere eccipienti ausiliari quali ad esempio conservanti, battericidi, profumi, antischiuma, addensanti, tensioattivi, emulsionanti, umettanti, grassi, cere, oli, elettroliti, solventi organici o derivati del silicone. The cosmetic compositions can include auxiliary excipients such as preservatives, bactericides, perfumes, defoamers, thickeners, surfactants, emulsifiers, humectants, fats, waxes, oils, electrolytes, organic solvents or silicone derivatives.
L’allestimento delle diverse forme cosmetiche può avvenire per semplice miscela fisica dei componenti a temperatura ambiente o, dove possibile, a temperature elevate. Nel caso di emulsioni la fase acquosa e la fase oleosa sono preparate separatamente e poi miscelate ed emulsionate, a temperatura ambiente o, dove possibile, a temperature elevate The preparation of the different cosmetic forms can take place by simple physical mixture of the components at room temperature or, where possible, at high temperatures. In the case of emulsions, the aqueous phase and the oily phase are prepared separately and then mixed and emulsified, at room temperature or, where possible, at high temperatures
Esempio 1 Example 1
Tonico analcolico idratante per viso Non-alcoholic moisturizing tonic for face
% in peso Acqua, conservanti % by weight Water, preservatives
q.b. 100 Carnosina q.s. 100 Carnosine
10 Saccaride isomerato 2 Proteina vegetale idrolizzata 10 Saccharide isomerate 2 Hydrolyzed vegetable protein
2 Gomma- 1 biosaccaride 2 Gum- 1 biosaccharide
5 Acqua, glicerina, camomilla recutita 5 Water, glycerin, chamomile recutita
5 PEG-40 idrogenato olio di ricino, PPG-26 0.4 buteth26 5 PEG-40 hydrogenated castor oil, PPG-26 0.4 buteth26
0.1 Profumo 0.1 Perfume
Regolare il pH a 5.5 con acido citrico Adjust the pH to 5.5 with citric acid
Esempio 2 Example 2
Lozione dopobarba idroalcolica Hydroalcoholic aftershave lotion
% in peso Acqua, conservanti % by weight Water, preservatives
q.b. 100 Carnosina q.s. 100 Carnosine
1 Acqua, alcol, hamammelis virginiana 1 Water, alcohol, hamammelis virginiana
45 Acido citrico (a lattico) 45 Citric acid (a lactic)
0.25 Allantoina 0.25 Allantoin
0.25 Pantenolo 0.25 Panthenol
1 PEG-40 idrogenato olio di ricino, PPG-26 1 buteth26 1 PEG-40 hydrogenated castor oil, PPG-26 1 buteth26
1 Profumo 1 Perfume
Esempio 3 Example 3
Gel idroalcolico Hydroalcoholic gel
% in peso % by weight
Acqua, conservanti q.b. 100 Carnosina 48 Alcol denaturato 5 Carbomer 1 Aminoetil propanolo 0.4 EDTA Na2 0.1 Esempio 4 Water, preservatives to taste 100 Carnosine 48 Denatured alcohol 5 Carbomer 1 Aminoethyl propanol 0.4 EDTA Na2 0.1 Example 4
Gel emolliente Emollient gel
% in peso % by weight
Acqua, conservanti q.b. 100 C amo sin a Water, preservatives to taste 100 I love since
10 Algae 10 Algae
5 Sodium carbomer 1 Proteina vegetale idrolizzata 5 Sodium carbomer 1 Hydrolyzed vegetable protein
2.5 PEG-40 idrogenato, olio di ricino, PPG-26 0.4 buteth26 2.5 Hydrogenated PEG-40, castor oil, PPG-26 0.4 buteth26
0.1 Profumo 0.1 Perfume
Esempio 5 Example 5
Gel contorno occhi Eye contour gel
% in peso % by weight
Acqua, conservanti q.b. 100 Carnosina . 2 Saccaride isomerato 2 Gliceril polimetacrilato 40 Water, preservatives to taste 100 Carnosine. 2 Saccharide isomerate 2 Glyceryl polymethacrylate 40
Esempio 6 Example 6
Gel fluido antietà Anti-aging fluid gel
% in peso % by weight
Acqua, conservanti q.b. 100 Carnosina 4 Poliacrilamide, Isoesadecano, Polisorbato 80 1.25 Glicerina 3 Profumo 0.25 Esempio 7 Water, preservatives to taste 100 Carnosine 4 Polyacrylamide, Isohexadecane, Polysorbate 80 1.25 Glycerin 3 Fragrance 0.25 Example 7
Emulsione gel iperfluida solare Hyperfluid solar gel emulsion
% in peso % by weight
Acqua q.b. 100 Carnosina 10 Acrilati/C]0.30 crosspolimero alchil acrilato 0.15 Metil glucosio dioleato 0.10 Ciclopentasiloxano 7.50 Dimeticone 1 Ottilmetossicinammato 5 Aminometilpropanolo 0.12 Profumo 0.38 Water q.s. 100 Carnosine 10 Acrylates / C] 0.30 crosspolymer alkyl acrylate 0.15 Methyl glucose dioleate 0.10 Cyclopentasiloxane 7.50 Dimethicone 1 Ottylmethoxycinamate 5 Aminomethylpropanol 0.12 Fragrance 0.38
Esempio 8 Example 8
Crema gel idratante Moisturizing gel cream
% in peso % by weight
Acqua, conservanti q.b. 100 Carnosina 2 Ottilottanoato 8 Acrilati/ crosspolimero isodecanoato acrilato 0.20 Ossibenzone 0.50 Lecitina, ascorbil palpitato, acido citrico 0.05 Carbomer 0.30 Aminometilpropanolo 0.40 Ciclopentasiloxano, dimeticonolo 1 Profumo 040 Esempio 9 Water, preservatives to taste 100 Carnosine 2 Octyloctanoate 8 Acrylates / crosspolymer isodecanoate acrylate 0.20 Oxybenzone 0.50 Lecithin, ascorbyl palpitate, citric acid 0.05 Carbomer 0.30 Aminomethylpropanol 0.40 Cyclopentasiloxane, dimethiconol 1 Perfume 040 Example 9
Emulsione corpo O/A Body emulsion O / A
% in peso % by weight
Acqua q.b. Carnosina 2 Sodio diidrossicetil fosfato 2.5 Cetereato-20 0.5 Acido Stearico 5 Dimeticone 0.5 Alcol cetearilico 0.5 Ottilottanoato 3 Bisabololo 0.3 Sodio carbomer 0.5 Glicerina 5 Profumo 0.38 Water q.s. Carnosine 2 Sodium dihydroxycetyl phosphate 2.5 Cetereate-20 0.5 Stearic acid 5 Dimethicone 0.5 Cetearyl alcohol 0.5 Octyloctanoate 3 Bisabolol 0.3 Sodium carbomer 0.5 Glycerin 5 Perfume 0.38
Esempio 10 Example 10
Emulsione corpo O/A Body emulsion O / A
% in peso % by weight
Acqua q.b. 100 Carnosina 2 Alcol cetearilico, sodio cetearil solfato 8 Etere dicaprilico 2 Ottildodecanolo 4 Acido glicolico 0.5 Acido malico 0.15 Acido tartarico 0.15 Acido citrico 0.1 Acido lattico 0.3 Sodio lattato 1 Sodio piruvato 0.3 Glicerina 3 Profumo q.b. Water q.s. 100 Carnosine 2 Cetearyl alcohol, sodium cetearyl sulphate 8 Dicapryl ether 2 Octyldodecanol 4 Glycolic acid 0.5 Malic acid 0.15 Tartaric acid 0.15 Citric acid 0.1 Lactic acid 0.3 Sodium lactate 1 Sodium pyruvate 0.3 Glycerin 3 Perfume q.s.
Esempio 11 Example 11
Latte per il corpo O/A Body milk O / A
% in peso % by weight
Acqua 71.25 Carnosina 5 Paraffina liquida 12 Isopropil palmitato 5 Antiossidante q-b. Sodio carbomer 0.75 Acido citrico (10%) 0.25 Laureth-4 fosfato, poligliceril-2 sesquiisostearato 3 Profumo 0.3 Water 71.25 Carnosine 5 Liquid paraffin 12 Isopropyl palmitate 5 Antioxidant q-b. Sodium carbomer 0.75 Citric acid (10%) 0.25 Laureth-4 phosphate, polyglyceryl-2 sesquiisostearate 3 Fragrance 0.3
Esempio 12 Example 12
Emulsione fluida A/O A / O fluid emulsion
% in peso % by weight
Acqua q.b. 100 Carnosina 2 Poligliceril-2 dipoiidrossistearato 2.5 Paraffina liquida, lanolina alchool 2.5 Trigliceride caprilico/caprico 5 C12-i5 alchil benzoato 7.5 Polidecene 7.5 Magnesio solfato 0.5 Profumo 0.5 Esempio 13 Water q.s. 100 Carnosine 2 Polyglyceryl-2 dipohydroxystearate 2.5 Liquid paraffin, lanolin alcohol 2.5 Caprylic / capric triglyceride 5 C12-i5 alkyl benzoate 7.5 Polydecene 7.5 Magnesium sulphate 0.5 Fragrance 0.5 Example 13
Crema A/O A / O cream
% in peso % by weight
Acqua q.b. 100 Carnosina 2 PEG-30 dipolidrossistearato 2 Ciclopentasiloxano 11 Sorbeth-30 3 C12-15 alchil benzoato 7 Magnesio solfato 0.5 Profumo 0.5 Water q.s. 100 Carnosine 2 PEG-30 dipolydroxystearate 2 Cyclopentasiloxane 11 Sorbeth-30 3 C12-15 alkyl benzoate 7 Magnesium sulphate 0.5 Fragrance 0.5
Esempio 14 Example 14
Stick lipidico anidro Anhydrous lipid stick
% in peso % by weight
Carnosina 0.5 Cera d’api 3-poligliceril 35 Mangifera indica 10 Teobroma cacao 10 OLUS 44 Aroma 0.5 Carnosine 0.5 Beeswax 3-polyglyceril 35 Mangifera indica 10 Theobroma cocoa 10 OLUS 44 Aroma 0.5
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000MI002855A ITMI20002855A1 (en) | 2000-12-29 | 2000-12-29 | COSMETIC USE OF CARNOSINE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000MI002855A ITMI20002855A1 (en) | 2000-12-29 | 2000-12-29 | COSMETIC USE OF CARNOSINE |
Publications (1)
Publication Number | Publication Date |
---|---|
ITMI20002855A1 true ITMI20002855A1 (en) | 2002-06-29 |
Family
ID=11446352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2000MI002855A ITMI20002855A1 (en) | 2000-12-29 | 2000-12-29 | COSMETIC USE OF CARNOSINE |
Country Status (1)
Country | Link |
---|---|
IT (1) | ITMI20002855A1 (en) |
-
2000
- 2000-12-29 IT IT2000MI002855A patent/ITMI20002855A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2701598T3 (en) | Use of natural active substances in cosmetic or therapeutic compositions | |
CA2749750C (en) | Skin care compositions and methods of use thereof | |
JP4974532B2 (en) | Use of at least one cypress plant extract as an anti-glycation agent | |
EP2467134B1 (en) | Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof | |
US20100119628A1 (en) | Anti-aging cosmetic composition | |
ES2653666T3 (en) | Cosmetic and / or pharmaceutical composition comprising a carob extract as an active agent for activating the expression of aquaporins | |
JP2010540574A (en) | Topically applied cosmetic or pharmaceutical composition | |
ES2604753T3 (en) | Cosmetic or dermatological use of peptides to increase adhesion between skin cells | |
KR20040021685A (en) | Cosmetic and/or pharmaceutical preparations containing plant extracts | |
KR102118751B1 (en) | Complex having dedifferentiated plant protoplast inserted active material, preparation method thereof, and cosmetic composition comprising the same | |
KR101105816B1 (en) | Method for the innoformulation of a biocompatible galenic base | |
KR20120003178A (en) | Composition with skin lightening and moisturizing effects containing bee venom extracts | |
KR20150066826A (en) | Cosmetics compositions for prevention and improvement of wrinkle | |
KR20130114493A (en) | Cosmetic compositions comprising the extract of dendropanax morbiferum as an active ingredient | |
KR102281606B1 (en) | A multifunctional cosmetic composition for elasticity, anti-wrinkle, inhibiting tyrosinase comprising peptide complex | |
KR100794518B1 (en) | A cosmetic composition containing a extract of Viola tricolor L. | |
KR102445188B1 (en) | A functional micro-n-recovery cosmetic composition for effective skin regeneration and anti-aging comprising microneedle, low molecular weight peptide and natural extracts | |
KR101009767B1 (en) | Cosmetic Composition for Desquamation Containing a Papain and the Extract of Nopal | |
KR102212894B1 (en) | Cosmetic Composition For Promoting Hair Volume Containing Walnut Peptides As Active Ingredient | |
ITMI20002855A1 (en) | COSMETIC USE OF CARNOSINE | |
KR20000055724A (en) | Moisturizing cosmetic compositions containing a beta-1,6-branched-beta-1,3-glucan | |
KR102382002B1 (en) | A multifunctional cosmetic composition for elasticity, anti-wrinkle, inhibiting tyrosinase comprising peptide complex and natural ingredients | |
JPH04282320A (en) | Cosmetic | |
KR102561289B1 (en) | Peptide for whitening and cosmetic composition with improved percutaneous absorption comprising the same | |
US20230183289A1 (en) | Preparing method of highly functional peptide derived from keratinocyte protein |